trending Market Intelligence /marketintelligence/en/news-insights/trending/rowextonc9rtrlzovgyndw2 content esgSubNav
In This List

Scythian Biosciences to list on Nasdaq Capital Market

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Scythian Biosciences to list on Nasdaq Capital Market

Scythian Biosciences Corp. received approval to list its common shares on the Nasdaq Capital Market.

The company's common shares will trade on Nasdaq under the symbol SCYB, starting Feb. 22.